Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1099, pseudogene (RNU6-1099P) is a processed pseudogene found in humans that resembles the U6 small nuclear RNA gene, an essential component of spliceosomal snRNPs involved in mRNA splicing[1][3]. Unlike the functional U6 snRNA, RNU6-1099P does not produce a functional product and is categorized as a non-coding genetic element. While pseudogenes can play regulatory roles at the RNA level—such as acting as decoys for miRNAs or producing non-coding RNAs that modulate gene expression—there are currently no specific functional, pathogenic, or pharmacological roles documented for RNU6-1099P[1][2]. Its classification as a pseudogene implies that it should not be construed as a direct drug target or conventional receptor/enzyme/transporter. The inclusion of this entity may reflect erroneous or overly broad target selection for drug discovery or mechanistic studies[1][2].
Not applicable (no drugs or interventions directly target RNU6-1099P specifically)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1099, pseudogene (RNU6-1099P).